Anil Vij, the Health Minister of Haryana, is in critical condition and has been admitted to Gurugram’s Medanta Hospital.
Vij has been battling the coronavirus infection and had been admitted to the Post-Graduate Institute of Medical Sciences (PGIMS) in Rohtak on Saturday where he had received convalescent plasma therapy.
The minister is currently undergoing treatment under Dr. Sushila Kataria, the senior director of the Internal Medicine Department at Medanta. Media reports allege that the minister is suffering from a lung infection, although no official response was given by the hospital.
In November, Vij had received a jab of the two-dose trial of the indigenously developed Covaxin. Developed by Hyderabad-based Bharat Biotech, the minister offered to be a volunteer in its Phase 3 trials.
The health minister was given the dose on November 20 at the Civil Hospital in Ambala Cantonment. Subsequently, on December 5 he tested positive for the virus triggering questions on the efficacy of the vaccine.
However, Bharat Biotech contends that the clinical trials of Covaxin are based on a two-dose schedule which is given 28-days apart. According to them, the vaccine’s efficacy can be determined two weeks after the second dose. Their statement added that the indigenously developed vaccine is designed to be protective two weeks after volunteers receive the second dose.
Even the Union Health Ministry also defended Covaxin as a two-dose vaccine and that the minister was given only the first dose. This was also just a fortnight before he tested positive. The ministry in a statement said, “The antibodies against the infection build up in a human being only after a specific number of days pass after the second dose of the vaccine is taken. This is a two-dose vaccine. The minister in question has taken only one dose of the vaccine.”
- World Contraception Day 2021: Why we must learn about contraception
- Bengaluru FC beat gritty Army Green 3-2 to enter Durand Cup semifinals
- Assam claims PFI behind police-peasant conflict in Sipajhar
- Arunachal will benefit most from oil palm cultivation: Khandu
- Legislature needs to revisit laws to suit ‘practical realities’: CJI
- Cong questions Shah’s silence over Assam border row, Sipajhar